Our results support the hypothesis that some gastric IPMNs can progress to tubular adenocarcinoma through pancreatobiliary morphology with IL‐18‐driven immunosuppression as a possible mechanism for this progression [55]. The gene discussed is IL18; the disease is tubular adenocarcinoma.